Current and emerging biologics for the treatment of pediatric atopic dermatitis [PDF]
Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by erythematous lesions, pruritus, and a skin barrier defect.
Balogh, Esther A. +4 more
core +1 more source
IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis. [PDF]
Despite robust literature associating IL-31 with pruritic inflammatory skin diseases, its influence on cutaneous inflammation and the interplay between inflammatory and neurosensory pathways remain unmapped.
Ansel, Karl +15 more
core +1 more source
Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab [PDF]
Prurigo nodularis (PN) is a debilitating, difficult-to-treat, intensely pruritic, chronic inflammatory skin disease characterized by hyperkeratotic skin nodules. The pathogenesis of PN is not well understood but is believed to involve cross talk between sensory nerve fibers, immune cells, and the epidermis.
Lam C, Tsoi +15 more
openaire +2 more sources
Az atópiás dermatitis patomechanizmusa [PDF]
L
Steuer-Hajdu, Krisztina, Szegedi, Andrea
core +1 more source
Generalized prurigo nodularis after dermatomal herpes zoster: Resolution with nemolizumab. [PDF]
Fason C, Tyring S.
europepmc +2 more sources
Dupilumab: A new paradigm for the treatment of allergic diseases [PDF]
Moderate and severe forms of allergic diseases such as atopic dermatitis and asthma are a challenge for clinicians. In these conditions, which severely affect the quality of life of the patient and frequently have associated allergic comorbidities, the ...
Dávila, Ignacio, Sastre, Joaquín
core +2 more sources
Characterization of the effects on pruritus by novel treatments for atopic dermatitis [PDF]
Chronic pruritus is a common and debilitating symptom in patients with atopic dermatitis and contributes to impairment of quality of life. Effective treatment of pruritus should therefore be one of the main treatment goals in patients with atopic ...
Bonnekoh, Hanna +2 more
core +1 more source
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
Prurigo nodularis is a chronic, debilitating, and severely pruritic neuroimmunologic skin disease. Nemolizumab, an interleukin-31 receptor alpha antagonist, down-regulates key pathways in the pathogenesis of prurigo nodularis.In this phase 3, double-blind, multicenter, randomized trial, we assigned adults with moderate-to-severe prurigo nodularis to ...
Kwatra, Shawn G +24 more
openaire +5 more sources
Pruritus represents one of the most common symptoms in dermatology and general medicine. Chronic pruritus severely impairs the quality of life of affected patients.
Jana Maria Nemmer +8 more
doaj +1 more source
Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients [PDF]
Atopic dermatitis; Memory T cells; PruritusDermatitis atòpica; Cèl·lules T de memòria; PruritDermatitis atópica; Células T de memoria; PruritoBackground: The role of allergen sensitization in IL-31 production by T cells and specifically in the clinical ...
Bonfill Ortí, Montserrat +5 more
core +5 more sources

